NMPA-2021-0084-V284

Type IB variation for application NMPA-2021-0084. Type IB variation: Facility Change for Glucovantib — critical change

Variation Number
NMPA-2021-0084-V284
Type
Type IB
Application
NMPA-2021-0084
Change
CHG-2021-0284
Status
Submitted
Fee
€1,053
Submitted
2022-11-21
Approved
—
Description

Type IB variation: Facility Change for Glucovantib — critical change